Adc Therapeutics Sa (ADCT)

02:10 AM

Is ADC Therapeutics SA a good long term investmentHigh-yield market plays - PrintWeekIndia

02:10 AM

Jul 24, 2025

What analysts say about ADC Therapeutics SA stockExceptional market performance - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

What drives ADC Therapeutics SA stock priceBreakout stock performance - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

ADC Therapeutics SA Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com

Jul 22, 2025

Jul 16, 2025

ADC Therapeutics’ LOTIS-10 Study: A Potential Game-Changer in Lymphoma Treatment - TipRanks

Jul 16, 2025

Jul 15, 2025

What makes ADC Therapeutics SA stock price move sharplyCapital Growth Picks - Newser

Jul 15, 2025

Jul 15, 2025

Why ADC Therapeutics SA stock attracts strong analyst attentionFree Market Sentiment Analysis - Newser

Jul 15, 2025

Jul 15, 2025

How ADC Therapeutics SA stock performs during market volatilityFree Exclusive Stock Market Insights - Newser

Jul 15, 2025

Jul 15, 2025

ADC Therapeutics (NYSE:ADCT) Shares Down 4.2%What's Next? - MarketBeat

Jul 15, 2025

Jul 14, 2025

Adc Therapeutics Sa shares fall 1.88% after-hours as Sonnet Biotherapeutics, Inc. announces $888 million funding. - AInvest

Jul 14, 2025

Jul 12, 2025

ADC Therapeutics (NYSE:ADCT) Shares Down 4.2% – Here’s Why - Defense World

Jul 12, 2025

Jul 05, 2025

ADC Therapeutics announces $100M private financing - MSN

Jul 05, 2025

Jul 02, 2025

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan - The Malaysian Reserve

Jul 02, 2025

Jun 30, 2025

ADC Therapeutics (ADCT) Files Prospectus for Share Sale - GuruFocus

Jun 30, 2025

Jun 30, 2025

ADCT SEC FilingsAdc Therapeutics Sa 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 30, 2025

Jun 26, 2025

The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? - Weekly Voice

Jun 26, 2025

Jun 24, 2025

ADC reports data from lymphoma trial, streamlines operations - MSN

Jun 24, 2025

Jun 23, 2025

ADC Therapeutics (NYSE:ADCT) Stock Rating Upgraded by Royal Bank Of Canada - MarketBeat

Jun 23, 2025

Jun 20, 2025

ADC Therapeutics (ADCT) Price Target Lowered by RBC Capital | AD - GuruFocus

Jun 20, 2025

Jun 20, 2025

ADC Therapeutics price target lowered to $5 at RBC on growth outlook - Investing.com

Jun 20, 2025

Jun 18, 2025

ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes - Quantisnow

Jun 18, 2025

Jun 17, 2025

Adc Therapeutics SA (NYSE: ADCT) Continues Its Downward Trend - Stocksregister

Jun 17, 2025

Jun 17, 2025

ADC Therapeutics Announces Updated ZYNLONTA Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma - marketscreener.com

Jun 17, 2025

Jun 16, 2025

ZYNLONTA shows 85% response rate in marginal zone lymphoma trial By Investing.com - Investing.com Nigeria

Jun 16, 2025

Jun 16, 2025

ZYNLONTA shows 85% response rate in marginal zone lymphoma trial - Investing.com Australia

Jun 16, 2025

Jun 16, 2025

Breakthrough Lymphoma Treatment: ZYNLONTA Shows 85% Response Rate with 27-Month Durability in Latest Trial - Stock Titan

Jun 16, 2025

Jun 16, 2025

Switzerland: ADC Therapeutics raises US$100m from PIPE financing - Investors in Healthcare

Jun 16, 2025

Jun 15, 2025

Guggenheim Reaffirms Buy Rating for ADC Therapeutics (NYSE:ADCT) - Defense World

Jun 15, 2025

Jun 15, 2025

ADC Therapeutics (NYSE:ADCT) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World

Jun 15, 2025

Jun 14, 2025

Analysts Set Expectations for ADCT FY2026 Earnings - MarketBeat

Jun 14, 2025

Jun 14, 2025

Guggenheim Raises Price Target for ADC Therapeutics (ADCT) | ADCT Stock News - GuruFocus

Jun 14, 2025

Jun 13, 2025

ADC Therapeutics (ADCT) Price Target Raised Amid Strategic Moves - GuruFocus

Jun 13, 2025